Pharvaris N.V. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported net loss was EUR 21.9 million compared to EUR 12.62 million a year ago. Basic loss per share from continuing operations was EUR 0.63 compared to EUR 0.38 a year ago.
For the six months, net loss was EUR 44.53 million compared to EUR 28.65 million a year ago. Basic loss per share from continuing operations was EUR 1.3 compared to EUR 0.86 a year ago.